Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials

Rao, 1995, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound, Cancer Res, 55, 259 Kelloff, 1996, Strategy and planning for chemopreventive drug development: clinical development plans II, J Cell Biochem, 63, 54, 10.1002/jcb.240630705 Kawamori, 1999, Chemopreventative effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer, Cancer Res, 59, 597 Mahmoud, 2000, Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis, Carcinogenesis, 21, 921, 10.1093/carcin/21.5.921 Perkins, 2002, Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis, Cancer Epidemiol Biomarkers Prev, 11, 535 Vogelstein, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901 Sharma, 2005, Curcumin: The story so far, Eur J Cancer, 41, 1955, 10.1016/j.ejca.2005.05.009 Sharma, 2004, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin Cancer Res, 10, 6847, 10.1158/1078-0432.CCR-04-0744 Garcea, 2005, Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences, Cancer Epidemiol Biomarkers Prev, 14, 120, 10.1158/1055-9965.120.14.1 Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895 Ireson, 2001, Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production, Cancer Res, 61, 1058 Plummer, 1999, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980 Jovanovic, 1998, H-atom transfer is a preferred antioxidant mechanism of curcumin, J Am Chem Soc, 121, 9677, 10.1021/ja991446m Sharma, 2001, Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels, Clin Cancer Res, 7, 1452 Marnett, 2000, Oxyradicals and DNA damage, Carcinogenesis, 21, 361, 10.1093/carcin/21.3.361 Sharma, 2001, Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells, Carcinogenesis, 9, 1557, 10.1093/carcin/22.9.1557 Wang, 1996, Lipid peroxidation induced putative malondialdehyde-DNA adducts in human breast tissues, Cancer Epidemiol Biomarkers Prev, 5, 705 Dedon, 1998, Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal, Proc Natl Acad Sci USA, 95, 11113, 10.1073/pnas.95.19.11113 Feig, 1994, Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA, Proc Natl Acad Sci USA, 91, 6609, 10.1073/pnas.91.14.6609 Cheng, 1992, 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions, J Biol Chem, 267, 166, 10.1016/S0021-9258(18)48474-8 Nakamura, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901 Singh, 1995, Activation of transcription factor NF-kappaB is suppressed by curcumin (diferulolylmethane), J Biol Chem, 270, 24995, 10.1074/jbc.270.42.24995 Plummer, 2001, Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents, Cancer Epidemiol Biomarkers Prev, 10, 1295 Bamba, 1999, High expression of cyclooygenase-2 in macrophages of human colonic adenoma, Int J Cancer, 83, 470, 10.1002/(SICI)1097-0215(19991112)83:4<470::AID-IJC6>3.0.CO;2-F Hull, 1999, Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice, Br J Cancer, 79, 1399, 10.1038/sj.bjc.6690224 Sinicrope, 1999, Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers, Gastroenterology, 117, 350, 10.1053/gast.1999.0029900350 Jacoby, 2000, The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis, Cancer Res, 60, 5040 Workman, 1998, United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (2nd ed.), Br J Cancer, 77, 1, 10.1038/bjc.1998.1 Luongo, 1994, Loss of Apc (+) in intestinal adenomas from Min mice, Cancer Res, 54, 5947 Leuratti, 1998, Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay, Carcinogenesis, 19, 1919, 10.1093/carcin/19.11.1919 Singh, 2003, An improved liquid chromatography–mass spectrometry/mass spectrometry method for the determination of 8-hydroxy-2′-deoxyguanosine in DNA samples using immunoaffinity column purification, Rapid Commun Mass Spec, 17, 126, 10.1002/rcm.883 Takeda, 2003, Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis, Cancer Res, 63, 4872 Seno, 2002, Cyclooxygenase 2- and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps, Cancer Res, 62, 506 Steinbach, 2000, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603 Boolbol, 1996, Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, 56, 2556 Giardiello, 1993, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N Engl J Med, 328, 1313, 10.1056/NEJM199305063281805 Leuratti, 2002, Detection of malondialdehyde-DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas, Cancer Epidemiol Biomarkers Prev, 11, 267 Eberhart, 1994, Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Uefuji, 2001, Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas, J Surg Oncol, 76, 26, 10.1002/1096-9098(200101)76:1<26::AID-JSO1005>3.0.CO;2-A